Rexulti 0.5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FX37W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,448
Award facts
- Contract value 100% obligated
- $3,448.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,448.30 to AmerisourceBergen Drug Corp for supply of REXULTI 0.5 mg tablets (30-count packages). This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
REXULTI (brexpiprazole) is an atypical antipsychotic medication used in the treatment of schizophrenia and as an adjunctive therapy for major depressive disorder. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad range of medications and medical products to support military healthcare systems, the Defense Health Agency, and other government healthcare organizations. This delivery order exemplifies the company's role in fulfilling specialized pharmaceutical requirements through the DLA's pharmaceutical prime vendor program, which ensures reliable access to critical medications for the defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FX37W?
SPE2DB25FX37W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FX37W worth?
The government has obligated $3,448 on SPE2DB25FX37W.
Is contract SPE2DB25FX37W an order under another contract?
Yes. SPE2DB25FX37W is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX37W competed?
The extent of competition for SPE2DB25FX37W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award